Journal article
Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial
Early Intervention in Psychiatry, Vol.10(4), pp.290-299
2016
Abstract
Aim: US authorities have recommended 'black-box' warnings for antidepressants because of the increased risk of suicidality for individuals up to age 25. There is thus a clinical and ethical imperative to provide effective treatment for youth depression with an acceptable risk-benefit balance. Long-chain omega-3 polyunsaturated fatty acids (PUFAs) play an important role in a range of physiological processes in living organisms. Supplementation with omega-3 PUFAs has been shown to have a range of beneficial effects on both physical and mental health, and results of previous trials suggest that omega-3 PUFAs may be a safe and effective treatment for depression. However, conclusions from these trials have been limited by their relatively small sample sizes. Methods: This trial will test the effectiveness of a 12-week parallel group, double-blind, randomized, placebo-controlled trial of 1.4 g day-1 omega-3 PUFAs in help seeking 15- to 25-year-olds (N = 400) presenting with major depressive disorder. The primary hypothesis is that young people will show greater improvement of depressive symptoms after 12 weeks of treatment with omega-3 PUFAs plus cognitive behavioural case management compared with treatment with placebo plus cognitive behavioural case management. Conclusion: Because of using a large sample, results from this study will provide the strongest evidence to date to inform the use of omega-3 PUFAs as first-line therapy in young people presenting with major depressive disorder. The study also heralds an important step towards indicated prevention of persistent depression, which may reduce the burden, stigmatization, disability and economic consequences of this disorder. © 2014 Wiley Publishing Asia Pty Ltd
Details
- Title
- Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial
- Authors
- S M Rice (Author) - University of MelbourneI B Hickie (Author) - University of SydneyA R Yung (Author) - University of Manchester, United KingdomA Mackinnon (Author) - University of MelbourneM Berk (Author) - University of MelbourneC Davey (Author) - University of MelbourneDaniel F Hermens (Author) - University of SydneyS E Hetrick (Author) - University of MelbourneA G Parker (Author) - University of MelbourneM R Schäfer (Author) - University of MelbourneP D McGorry (Author) - University of MelbourneG P Amminger (Author) - University of Melbourne
- Publication details
- Early Intervention in Psychiatry, Vol.10(4), pp.290-299
- Publisher
- Wiley-Blackwell Publishing Asia
- Date published
- 2016
- DOI
- 10.1111/eip.12166
- ISSN
- 1751-7885
- Organisation Unit
- University of the Sunshine Coast, Queensland; Thompson Institute
- Language
- English
- Record Identifier
- 99450545102621
- Output Type
- Journal article
Metrics
438 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web Of Science research areas
- Psychiatry
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites